Evidence map›Paper›PMID 34572432›Full record

ArticleBiomedicines2021

Oral Capsaicinoid Administration Alters the Plasma Endocannabinoidome and Fecal Microbiota of Reproductive-Aged Women Living with Overweight and Obesity.

Claudia Manca, Sébastien Lacroix, Francine Pérusse, Nicolas Flamand, Yvon Chagnon, Vicky Drapeau, Angelo Tremblay, Vincenzo Di Marzo, Cristoforo Silvestri

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Energy metabolism in health and diseases.Signal transduction and targeted therapy · 2025
    Review
  3. Review
  4. Article
  5. Heat-killedFrontiers in nutrition · 2024
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Claudia MancaDépartement de Médecine, Faculté de Médecine, Université Laval, Québec, QC G1V 0A6, Canada.ORCID 0000-0002-4081-9550
Sébastien LacroixCanada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health, Québec, QC G1V 4G5, Canada.
Francine PérusseNutrition, Santé et Société (NUTRISS), Institut sur la Nutrition et les Aliments Fonctionnels (INAF), Université Laval, Québec, QC G1V 0A6, Canada.
Nicolas FlamandDépartement de Médecine, Faculté de Médecine, Université Laval, Québec, QC G1V 0A6, Canada.ORCID 0000-0001-5944-7200
Yvon ChagnonDépartement de Médecine, Faculté de Médecine, Université Laval, Québec, QC G1V 0A6, Canada.
Vicky DrapeauInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC G1V 4G5, Canada.
Angelo TremblayInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC G1V 4G5, Canada.
Vincenzo Di MarzoDépartement de Médecine, Faculté de Médecine, Université Laval, Québec, QC G1V 0A6, Canada.
Cristoforo SilvestriDépartement de Médecine, Faculté de Médecine, Université Laval, Québec, QC G1V 0A6, Canada.ORCID 0000-0001-5635-1545
Institut universitaire de cardiologie et de pneumologie de Québec · CAUniversité Laval · CA

Funding

CIHR 37392 and 37858
6 · The paper itself

Abstract

Capsaicinoids, the pungent principles of chili peppers and prototypical activators of the transient receptor potential of the vanilloid type-1 (TRPV1) channel, which is a member of the expanded endocannabinoid system known as the endocannabinoidome (eCBome), counteract food intake and obesity. In this exploratory study, we examined the blood and stools from a subset of the participants in a cohort of reproductive-aged women with overweight/obesity who underwent a 12-week caloric restriction of 500 kcal/day with the administration of capsaicinoids (two capsules containing 100 mg of a capsicum annuum extract (CAE) each for a daily dose of 4 mg of capsaicinoids) or a placebo. Samples were collected immediately before and after the intervention, and plasma eCBome mediator levels (from 23 participants in total, 13 placebo and 10 CAE) and fecal microbiota taxa (from 15 participants in total, 9 placebo and 6 CAE) were profiled using LC-MS/MS and 16S metagenomic sequencing, respectively. CAE prevented the reduced caloric-intake-induced decrease in beneficial eCBome mediators, i.e., the TRPV1, GPR119 and/or PPARα agonists,

Indexed as

capsaicinoidsendocannabinoidomefood intakelipidomicsmetabolismmicrobiotaobesityoverweight

Identifiers

PMID34572432
PMCPMC8471891
OpenAlexW3201100674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.